Marsh & McLennan Companies, Inc. (MMC)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	100,129	104,319	93,422	82,080	87,761	59,341
Market Cap Growth	3.59%	11.66%	13.82%	-6.47%	47.89%	5.54%
Enterprise Value	120,062	117,494	106,296	94,788	99,500	72,099
Last Close Price	203.67	210.01	184.63	158.96	164.64	109.16
PE Ratio	24.46	25.69	24.87	26.91	27.92	29.44
Forward PE	20.51	23.04	22.35	22.78	26.23	23.21
PS Ratio	3.88	4.26	4.11	3.96	4.43	3.45
PB Ratio	6.35	7.71	7.55	7.64	7.82	6.41
P/FCF Ratio	21.51	26.17	24.32	27.41	28.22	19.56
P/OCF Ratio	20.36	24.25	21.94	23.69	24.96	17.55
PEG Ratio	2.45	2.62	1.94	2.49	1.95	2.50
EV/Sales Ratio	4.65	4.80	4.68	4.58	5.02	4.19
EV/EBITDA Ratio	15.84	16.26	16.15	16.74	18.09	17.74
EV/EBIT Ratio	17.81	18.13	18.12	19.18	20.94	21.70
EV/FCF Ratio	25.80	29.48	27.67	31.65	31.99	23.76
Debt / Equity Ratio	1.35	1.62	1.25	1.25	1.17	1.47
Debt / EBITDA Ratio	2.69	2.85	2.20	2.20	2.19	2.96
Debt / FCF Ratio	4.64	5.49	4.02	4.50	4.23	4.48
Asset Turnover	0.48	0.47	0.49	0.53	0.59	0.54
Quick Ratio	0.55	0.51	0.51	0.43	1.15	1.17
Current Ratio	1.20	1.13	1.10	1.06	1.24	1.24
Return on Equity (ROE)	28.41%	31.79%	32.89%	28.10%	30.99%	23.79%
Return on Assets (ROA)	7.86%	7.75%	7.96%	7.87%	8.81%	6.45%
Return on Capital (ROIC)	12.65%	12.82%	14.10%	12.71%	12.58%	9.23%
Return on Capital Employed (ROCE)	17.20%	17.50%	20.80%	18.80%	17.10%	12.50%
Earnings Yield	4.12%	3.89%	4.02%	3.72%	3.58%	3.40%
FCF Yield	4.65%	3.82%	4.11%	3.65%	3.54%	5.11%
Dividend Yield	1.77%	1.50%	1.47%	1.45%	1.26%	1.70%
Payout Ratio	40.18%	36.92%	34.21%	36.88%	32.26%	46.23%
Buyback Yield / Dilution	0.60%	0.60%	1.19%	1.56%	-0.19%	-0.20%
Total Shareholder Return	2.37%	2.10%	2.66%	3.01%	1.06%	1.50%

Updated Jul 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q